deltatrials
Completed PHASE1 INTERVENTIONAL 9-arm NCT03570918

MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy

A Phase 1 Study to Evaluate the Safety, Immunologic and Virologic Responses of MGD014 Therapy in HIV-Infected Individuals on Suppressive Antiretroviral Therapy

Sponsor: MacroGenics

Conditions HIV-1-infection
Interventions MGD014
Updated 13 times since 2018 Last updated: Aug 31, 2022 Started: Sep 25, 2018 Primary completion: Sep 28, 2021 Completion: Sep 28, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates HIV-1-infection and is currently completed. MacroGenics leads this study, which shows 13 recorded versions since 2018 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshot~Sep 2018 – ~Nov 2018 · 2 months · monthly snapshot~Nov 2018 – ~Jun 2019 · 7 months · monthly snapshot~Jun 2019 – ~Sep 2020 · 15 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Nov 2021 · 8 months · monthly snapshot~Nov 2021 – ~Sep 2022 · 10 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 21 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE1

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE1

  5. Sep 2022 — Dec 2022 [monthly]

    Completed PHASE1

▶ Show 8 earlier versions

  1. Nov 2021 — Sep 2022 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  2. Mar 2021 — Nov 2021 [monthly]

    Recruiting PHASE1

  3. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE1

  4. Sep 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  5. Jun 2019 — Sep 2020 [monthly]

    Recruiting PHASE1

  6. Nov 2018 — Jun 2019 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  7. Sep 2018 — Nov 2018 [monthly]

    Not Yet Recruiting PHASE1

  8. Jul 2018 — Sep 2018 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • MacroGenics
  • National Institute of Allergy and Infectious Diseases (NIAID)
Data source: MacroGenics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations